Website
41
|
EMQ. Maternal mortality definitions
|
42
|
EMQ. Zika virus and pregnancy
|
43
|
EMQ. BRCA1 & 2
|
44
|
EMQ. Cervical cancer staging
|
Option List.
1.
Death of a woman during pregnancy and up to 6 weeks
later, including accidental and incidental causes.
2.
Death of a woman during pregnancy and up to 6
weeks later, excluding accidental and incidental causes.
3.
Death of a woman during pregnancy and up to 52
weeks later, including accidental and incidental causes.
4.
Death of a woman during pregnancy and up to 52
weeks later, excluding accidental and incidental causes.
5.
A pregnancy going to 24 weeks or beyond.
6.
A pregnancy going to 24 weeks or beyond + any
pregnancy resulting in a live-birth.
7.
Maternal deaths per 100,000 maternities.
8.
Maternal deaths per 100,000 live births.
9.
Direct + indirect deaths per 100,000
maternities.
10.
Direct + indirect deaths per 100,000 live
births.
11.
Direct death.
12.
Indirect death.
13.
Early death.
14.
Late death.
15.
Extra-late death.
16.
Fortuitous death.
17.
Coincidental death.
18.
Accidental death.
19.
Maternal murder.
20.
Not a maternal death.
21.
Yes
22.
No.
23.
I have no idea.
24.
None of the above.
Abbreviations.
MMR: Maternal Mortality Rate.
MMRat: Maternal Mortality Ratio.
SUDEP: Sudden Unexplained Death
in Epilepsy.
Scenario 1. What is a Maternal Death?
Scenario 2. A woman dies from a ruptured ectopic pregnancy at 10 weeks’ gestation.
What kind of death is it?
Scenario 3. A woman dies from a ruptured appendix at 10 weeks’ gestation. What kind
of death is it?
Scenario 4. A woman
dies from suicide at 10 weeks’ gestation. What kind of death is it?
Scenario 5. A woman
with a 10-year-history of coronary artery disease dies of a coronary thrombosis
at 36 weeks’ gestation. What kind of death is it?
Scenario 6. A woman has gestational trophoblastic disease, develops choriocarcinomas
and dies from it 24 months after the GTD was diagnosed and the uterus
evacuated. What kind of death is it?
Scenario 7. A woman develops puerperal psychosis from which she makes a poor
recovery. She kills herself when the baby is 18 months old. What kind of death is it?
Scenario 8. A woman develops puerperal psychosis from which she makes a poor
recovery. She kills herself when the baby is 6 months old. What kind of death is it?
Scenario 9. What is a “maternity”.
Scenario 10. What is
the definition of the Maternal Mortality Rate?
Scenario 11. What is the Maternal Mortality Ratio?
Scenario 12. A woman is diagnosed with breast cancer. She has missed a period and a
pregnancy test is +ve. She decides to continue with the pregnancy. The breast
cancer does not respond to treatment and she dies from secondary disease at 38
weeks. What kind of death is it?
Scenario 13. A woman who has been the subject of domestic violence is killed at 12
weeks’ gestation by her partner. What kind of death is it?
Scenario 14. A woman is struck by lightning as she runs across a road. As a result
she falls under the wheels of a large lorry which runs over abdomen, rupturing
her spleen and provoking placental abruption. She dies of haemorrhage, mostly
from the abruption. What kind of death is it?
Scenario 15. A woman is abducted by Martians who are keen to study human pregnancy.
She dies as a result of the treatment she receives. As this death could only
have occurred because she was pregnant, is it a direct death?
Scenario 16. Could a maternal death from malignancy be classified as “Direct”.
Scenario 17. Could a maternal death from malignancy be classified as “Indirect”.
Scenario 18. Could a maternal death from malignancy be classified as “Coincidental”?
Scenario 19. A pregnant woman is walking on the beach at 10 weeks when she is struck
by lightning and dies. What kind of death is this?
Scenario 20. A woman is sitting on the beach breastfeeding her 2-month old baby when
she is struck by lightning and dies. What kind of death is this.
Abbreviations.
CZVS: Congenital
Zika Virus Syndrome.
FMS: fetal
medicine specialist.
HC head
circumference.
PCR: polymerase
chain reaction.
RTPCR: Reverse
transcription polymerase chain reaction
Question 1.
What kind of virus
is Zika?
A
|
DNA
|
B
|
DNA + RNA during intermediate stage
|
C
|
RNA
|
D
|
RNA + DNA during intermediate stage
|
Question 2.
To which family of
viruses does the Zika virus belong?
A
|
adenoviruses
|
B
|
flaviviruses
|
C
|
herpesviruses
|
D
|
orthomyxoviruses
|
E
|
parvoviruses
|
F
|
picornaviruses
|
G
|
retroviruses
|
H
|
togaviruses
|
Question 3.
What other human
infections are caused by viruses from this family? This is not a proper EMQ:
there may be more than one correct answer.
A
|
bubonic plague
|
B
|
chikungunya
|
C
|
chicken pox
|
D
|
common cold
|
E
|
dengue
fever
|
F
|
hepatitis C
|
G
|
Japanese
encephalitis
|
H
|
malaria
|
I
|
San Francisco
encephalitis
|
J
|
St. Louis
encephalitis
|
K
|
West Nile virus
|
L
|
Yellow fever
|
Question 4.
When was the first
reported identification of Zika virus infection in an animal and what was the
animal?
A
|
1922 in a hippopotamus
|
B
|
1928 is a
giraffe
|
C
|
1935 in a
macaque monkey
|
D
|
1947 in a Rhesus
negative monkey
|
E
|
1950 in a
chimpanzee
|
H
|
none of the
above.
|
Question 5.
Why is the virus
called “Zika”?
A
|
it was first described as “zoonosis
affecting Intestines, Kidneys and Adrenals”
|
B
|
the animal from which it was first
isolated was the Zika monkey
|
C
|
it was first isolated from a monkey from
the Zika area of Zambia
|
D
|
it was first isolated from a monkey from
the Zika forest in Uganda
|
E
|
it was first identified in the Zika
laboratory of the CDC
|
F
|
it was first identified by Dr Emily Zika,
Professor of Virology, Pretoria, S Africa
|
G
|
Zika is the Zulu word for ‘small head’ and
the association was 1st. noted in a Zulu baby
|
Question 6.
What is the main
reservoir of the Zika virus?
A
|
anteaters
|
B
|
horses
|
C
|
humans
|
D
|
marmosets
|
E
|
monkeys
|
F
|
parrots
|
G
|
rats
|
Question 7.
How is the Zika
virus transmitted? This is not a true EMQ as there may be > 1 correct
answer.
A
|
Aedes aegypti mosquitos
|
B
|
Aedes albopictus: Asian tiger mosquito
|
C
|
Anopheles gambiae mosquitos
|
D
|
Culex pipiens mosquitos
|
E
|
fleas
|
F
|
ticks
|
G
|
worms
|
H
|
none of the above.
|
Question 8.
At what time of
day is transmission of infection most likely?
A
|
afternoon
|
B
|
evening
|
C
|
morning
|
D
|
night
|
E
|
mid-morning and mid-afternoon to dusk
|
F
|
two hours after sunrise
|
G
|
two hours before sunset
|
H
|
two hours after sunset
|
I
|
two hours after sunrise and two hours
before sunset
|
J
|
none of the above
|
Question 9.
Where do aegypti
mosquitoes breed?
Which, if any of
the following
A
|
in large stretches of water with reed beds
|
B
|
in water near human habitation
|
C
|
in water remote from human habitation
|
D
|
in water in human habitations
|
E
|
in water with volume > 5 litres
|
F
|
in water with volume > 50 litres
|
G
|
in water with volume > 500 litres
|
H
|
none of the above.
|
Question 10.
When did the
current interest in the Zika virus and pregnancy begin and why?
A
|
Brazil reported an ↑ in microcephaly with a possible
link to maternal Zika infection in 2014
|
B
|
Brazil reported an ↑ in microcephaly with
a possible link to maternal Zika infection in 2015
|
C
|
Brazil reported an ↑ in microcephaly with
a possible link to maternal Zika infection in 2016
|
D
|
the CDC reported 3 cases of microcephaly
after proven Zika infection in pregnancy in 2014
|
E
|
the CDC reported 3 cases of microcephaly
after proven Zika infection in pregnancy in 2015
|
F
|
the CDC reported 3 cases of microcephaly
after proven Zika infection in pregnancy in 2016
|
H
|
none of the above
|
Question 11.
How did the WHO
categorise the problem and when?
A
|
Public Health Emergency of International
Concern 2015
|
B
|
Public Health Emergency of International
Concern 2016
|
C
|
Public Health Emergency of International
Concern 2017
|
D
|
Public Health Emergency of International
Concern 2018
|
E
|
none of the above
|
Question 12.
Is Zika virus
infection a notifiable condition in the UK?
A
|
No
|
B
|
Yes, but only if people have returned from
an area with a high prevalence of Zika
|
C
|
Yes, but only if the woman and her partner
have returned from an area with high prevalence of Zika
|
D
|
Yes, but only if fetal damage has
occurred.
|
E
|
none of the above
|
Question 13.
How is the risk of
getting a Zika virus infection from travelling to a particular country
categorised? Which, if any, of the following feature?
A
|
frightful
|
B
|
high
|
C
|
low
|
D
|
moderate
|
E
|
scary
|
F
|
none of the above
|
Question 14.
How long does it
take for symptoms of Zika infection to develop?
A
|
1 – 5 days
|
B
|
1 – 7 days
|
C
|
2 – 5 days
|
D
|
2 – 7 days
|
E
|
2 – 10 days
|
F
|
3 – 7 days
|
G
|
3 – 12 days
|
H
|
5 – 10 days
|
Question 15.
How long do
symptoms of Zika infection last?
A
|
1 – 5 days
|
B
|
1 – 7 days
|
C
|
2 – 5 days
|
D
|
2 – 7 days
|
E
|
2 – 10 days
|
F
|
3 – 7 days
|
G
|
3 – 12 days
|
H
|
5 – 10 days
|
Question 16.
What are the most
common symptoms of Zika infection? There is no option list – write what you
think.
Question 17.
Is Zika infection
more severe in pregnancy?
A
|
No
|
B
|
Yes
|
Question 18.
What abnormalities
have been associated with Congenital Zika Virus Syndrome? There is no option
list, just write as many as you can think of.
Question 19.
What is the
approximate risk of vertical transmission of the Zika virus in pregnancy?
A
|
10%
|
B
|
20%
|
C
|
30%
|
D
|
40%
|
E
|
≥
50%
|
E
|
the figure is unknown
|
Question 20.
Is gestation
related to the risk of vertical transmission of the Zika virus? Which, if any,
of the following statements are true?
A
|
evidence is unclear
|
B
|
evidence suggests it probably is
|
C
|
evidence suggests it probably is not
|
D
|
no
|
E
|
yes
|
Question 21.
What is the risk
of adverse fetal outcomes for women proven to have had Zika virus infection?
A
|
~ 5%
|
B
|
~ 10%
|
C
|
~ 15%
|
D
|
~ 20%
|
E
|
~ 25%
|
F
|
~30%
|
G
|
> 30%
|
H
|
none of the above
|
Question 22.
What advice should
be given to a pregnant woman planning to travel to an area with high risk of
transmission of Zika infection?
A
|
consider postponing travel until after the
pregnancy
|
B
|
don’t go to the area
|
C
|
get vaccinated
|
D
|
stay indoors from dawn to dusk
|
E
|
take chloroquine as prophylaxis
|
F
|
take chloroquine + proguanil as
prophylaxis
|
G
|
take proguanil as prophylaxis
|
Question 23.
What advice should
be given to a pregnant woman planning to travel to an area with moderate risk
of transmission of Zika infection?
A
|
consider postponing travel until after the
pregnancy
|
B
|
don’t go to the area
|
C
|
get vaccinated
|
D
|
stay indoors from dawn to dusk
|
E
|
take chloroquine as prophylaxis
|
F
|
take chloroquine + proguanil as
prophylaxis
|
G
|
take proguanil as prophylaxis
|
Question 24.
What advice should
be given to a woman who decides to travel to an area of high or moderate risk?
There is no option
list: jot down everything you think would be relevant.
Question 25.
A woman returns to
the UK from a high-risk Zika area? She develops symptoms suggestive of Zika
infection 4 weeks later. What testing should be offered?
A
|
abdominal ultrasound
|
B
|
amniocentesis
|
C
|
MR scan
|
D
|
no test indicated
|
E
|
TVS
|
F
|
Zika IgA
|
G
|
Zika IgG
|
H
|
Zika IgG + IgM
|
I
|
Zika IgA + IgG + IgM
|
J
|
Zika PCR
|
Question 26.
A woman who wishes
to be pregnant has returned to the UK from an area of high-risk for Zika
infection. Her partner had remained in the UK? What advice should she be given?
A
|
use barrier contraception for 8 weeks
|
B
|
use effective contraception for 8 weeks
|
C
|
use barrier contraception + effective
contraception for 8 weeks
|
D
|
use barrier contraception for 12 weeks
|
E
|
use effective contraception for 12 weeks
|
F
|
use barrier contraception + effective
contraception for 12 weeks
|
Question 27.
A man travels to
an area with high-risk of Zika infection? On his return to the UK his wife is
keen to start a pregnancy. What advice should be given?
A
|
use barrier contraception for 8 weeks
|
B
|
use effective contraception for 8 weeks
|
C
|
use effective contraception + barrier
contraception for 8 weeks
|
D
|
use barrier contraception for 12 weeks
|
E
|
use effective contraception for 12 weeks
|
F
|
use effective contraception + barrier contraception
for 12 weeks
|
G
|
use barrier contraception for 6 months
|
H
|
use effective contraception for 6 months
|
I
|
use effective contraception + barrier
contraception for 6 months
|
J
|
none of the above.
|
Question 28.
A man travels to
an area with high-risk of Zika infection for two weeks? During his stay he has
symptoms suggestive of Zika infection. His wife is pregnant. What testing
should be offered on his return?
A
|
discuss with local infection specialist
|
B
|
discuss with RIPL
|
C
|
no test indicated
|
D
|
Zika IgG
|
E
|
Zika IgG + IgM
|
F
|
Zika IgA + IgG + IgM
|
G
|
Zika PCR
|
H
|
none of the above
|
Question 29.
A woman is shown
to have had a Zika infection? How useful is amniocentesis for assessing the
risk to the fetus and determining if an infected fetus in affected?
A
|
PCR on amniocentesis is the gold standard
for diagnosing fetal infection
|
B
|
PCR on amniocentesis is of unknown value
for diagnosing fetal infection
|
C
|
PCR on amniocentesis is of little value
for diagnosing fetal infection
|
D
|
PCR on amniocentesis is the gold standard
for determining the risk of an infected fetus being affected
|
E
|
PCR on amniocentesis is of unknown value
for determining the risk of an infected fetus being affected
|
F
|
PCR on amniocentesis is of little value
for diagnosing fetal infection
|
Question 30.
What advice and
treatment should be offered to the non-pregnant individual with symptoms of
Zika infection? This is not a true EMQ as more than one option could be true.
A
|
adequate fluids
|
B
|
acyclovir from GP
|
C
|
bed rest for 48 hours
|
D
|
emergency contraception
|
E
|
get advice from A&E centre
|
F
|
offer TOP
|
G
|
paracetamol if needed for pain
|
Question 31.
A pregnant woman
returns from a high-risk Zika area and develops symptoms suggestive of
infection? She develops a high fever and is admitted to hospital. What
particular things should be done?
A
|
anticoagulant prophylaxis
|
B
|
paracetamol + tepid sponging
|
C
|
exclude chikungunya
|
D
|
exclude dengue
|
E
|
exclude malaria
|
F
|
exclude UTI
|
G
|
exclude Zika
|
H
|
exclude other causes of pyrexial illness
|
I
|
offer TOP
|
J
|
none of the above
|
Question 32.
A woman with
possible Zika exposure has a –ve test for virus antibodies 4 weeks after the
last possible exposure. Is this sufficiently long to reassure her that she has
not been infected?
A
|
no
|
B
|
yes
|
C
|
we don’t know
|
Question 33.
A pregnant woman
has visited a country with high-risk for Zika exposure but been asymptomatic
during her stay and for two weeks on her return? What testing should be
offered?
A
|
baseline ultrasound + repeat at 18-20
weeks
|
B
|
baseline ultrasound + repeat at 28-30
weeks
|
C
|
baseline ultrasound + repeat at 18-20
weeks + consider repeat at 28-30 weeks
|
D
|
amniocentesis
|
E
|
MR scan
|
F
|
no test indicated
|
G
|
Zika IgG
|
H
|
Zika IgG + IgM
|
I
|
Zika IgA + IgG + IgM
|
J
|
Zika PCR
|
Question 34.
A pregnant woman returns
to the UK from an area of high risk for Zika exposure has normal ultrasound
scans on her return and at 22 weeks. What further scans, if any, should be
arranged? This question is in the exam database.
A
|
monthly scans
|
B
|
scan at 28-30 weeks
|
C
|
scan at 32 and 36 weeks
|
D
|
scan at 36 weeks
|
E
|
no further scans
|
F
|
none of the above
|
Question 35.
A pregnant woman with
possible Zika exposure has an ultrasound scan showing the fetal BPD to be >
2 SDs below the mean for that gestation. What should be done?
A
|
discuss amniocentesis to confirm fetal
infection
|
B
|
discuss with the local virologist
|
C
|
offer TOP
|
D
|
refer to a fetal medicine specialist
|
E
|
screen the mother for recent Zika
infection
|
F
|
none of the above
|
Question 36.
A pregnant woman
with possible Zika exposure has an ultrasound scan showing significant brain
abnormality. What further testing should be discussed?
A
|
amniocentesis + PCR
|
B
|
amniocentesis + RT-PCR
|
C
|
MR scan
|
D
|
Zika IgG
|
E
|
Zika IgG + IgM
|
F
|
Zika IgA + IgG + IgM
|
G
|
none of the above
|
43. BRCA 1 & 2 carriers and risk of breast and ovarian
cancer.
Abbreviations.
BSO: bilateral
salpingo-oophorectomy
EOC: epithelial
ovarian cancer
HGSOG: high-grade
serous ovarian cancer
LGSOG: low-grade
serous ovarian cancer
SIP44: RCOG’s
Scientific Impact Paper No. 44, November 2014: “The Distal Fallopian Tube
as the Origin of Non-Uterine Pelvic High-Grade Serous Carcinomas”.
SIP48: RCOG’s
Scientific Impact Paper No. 48. February 2015. “Management of Women with a
Genetic Predisposition to Gynaecological Cancers.”
Scenario 1.
Which, if any,
of the following statements are true?
A
|
EOC is the
most common gynaecological cancer in the developed world
|
B
|
EOC is the
leading cause of death from gynaecological cancer in the developed world
|
C
|
50% of EOC is
mucinoid
|
D
|
HGSOG is 20
times more common than LGSOG
|
E
|
HGSOG is the
main cause of death from ovarian cancer
|
F
|
overall life
time risk of EOC is 1 in 70
|
G
|
the main risk
factors for EOC are cigarette smoking & older age
|
H
|
5% of ovarian
cancer is due to identified hereditary genetic factors
|
I
|
BRCA1 is
linked to an ↑ risk of breast, ovarian,
pancreatic and prostate cancer
|
J
|
BRCA2 is
linked to an ↑risk of breast, ovarian,
pancreatic and prostate cancer & melanoma
|
K
|
The prevalence
of BRCA1 & 2 mutations is about 1 in 400 in the general population
|
L
|
The prevalence
of BRCA1 & 2 mutations is about 1 in 40 in the Ashkenazi Jewish
population
|
M
|
The risk of
developing ovarian cancer by 75 years is BRCA1: 50% and BRCA2: 25%
|
N
|
EOC associated
with BRCA1 &2 is mostly low-grade mucinous in type
|
O
|
The risk of
male breast cancer is about 7% with BRCA2, higher than with BRCA1
|
P
|
BRCA1 & 2
are DNA repair genes
|
Q
|
male breast,
pancreatic and prostate cancer are more common with BRCA2 than BRCA1
|
Scenario 2.
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA1.
She attends the
gynaecology clinic requesting information about her lifetime risk of breast
cancer.
What is the
approximate figure?
Scenario 3.
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA1.
She attends the
gynaecology clinic requesting information about her lifetime risk of ovarian
cancer.
What is the
approximate figure?
Scenario 4.
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA2.
She attends the
gynaecology clinic requesting information about her lifetime risk of breast
cancer.
What is the
approximate figure?
Scenario 5.
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA2.
She attends the
gynaecology clinic requesting information about her lifetime risk of ovarian
cancer.
What is the
approximate figure?
Scenario 6.
The woman asks
for the overall figure for lifetime risk of breast cancer in UK women for
comparison with her risk.
What is the
approximate figure?
Scenario 7.
The woman asks
for the overall UK figure for lifetime risk of ovarian cancer for comparison
with her risk.
What is the
approximate figure?
Scenario 8
Which of the following genes have
mutations that increase the risk of breast cancer?
Answer.
A
|
ATM
|
B
|
CDH1
|
C
|
CHEK1
|
D
|
FATHEAD
|
E
|
MARBELLA.
|
F
|
NBENE
|
G
|
p45
|
H
|
p53.
|
I
|
PALB2
|
J
|
PNINE
|
K
|
PTEN
|
L
|
RADON50
|
M
|
RINT1
|
Scenario 9
A man of 30 has
two sisters who developed breast cancer before the age of 40. They and he have
been proved to be carriers of BRCA2.
His GP phones to
ask about his lifetime risk of breast cancer. What is the approximate figure?
Scenario 10
A man of 30 has
two sisters who developed breast cancer before the age of 40. They and he have
been proved to be carriers of BRCA2.
His GP phones to
ask about his lifetime risk of ovarian cancer. What is the approximate figure?
Scenario 11
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA2.
She attends the
gynaecology clinic requesting information about the value of prophylactic
mastectomy. What advice will you give about efficacy?
Scenario 12
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA2.
She attends the
gynaecology clinic requesting information about the benefits of prophylactic
salpingo-oophorectomy – her family is complete and her husband has had
vasectomy. What is the approximate figure for the efficacy of BSO in relation
to cancer?
Scenario 13.
Which, if any,
of the following statements is true in relation to the findings by Kuchenbaecker
in relation to the incidence of breast cancer in carriers of a BRCA1 mutation?
Pick one option
from the option list.
Option list.
A.
|
it rises
rapidly until the age of 30-40, then stays constant until age 80
|
B.
|
it rises
rapidly from puberty until the age of 30-40, then stays constant until age 80
|
C.
|
it rises
rapidly from young adulthood until the age of 30-40, then stays constant
until age 80
|
D.
|
it rises
rapidly from puberty until the age of 40-50, then stays constant until age 80
|
E.
|
it rises
rapidly from young adulthood until the age of 40-50, then stays constant
until age 80
|
F.
|
it rises
rapidly from puberty until the menopause, then stays constant until age 80
|
G.
|
it rises
rapidly from young adulthood until the menopause, then stays constant until
age 80
|
H.
|
none of the
above
|
Scenario 14.
Which, if any,
of the following statements is true in relation to the findings by Kuchenbaecker
in relation to the incidence of breast cancer in carriers of a BRCA2 mutation?
Pick one option
from the option list.
Option list.
A.
|
it rises
rapidly until the age of 30-40, then stays constant until age 80
|
B.
|
it rises
rapidly from puberty until the age of 30-40, then stays constant until age 80
|
C.
|
it rises
rapidly from young adulthood until the age of 30-40, then stays constant
until age 80
|
D.
|
it rises
rapidly from puberty until the age of 40-50, then stays constant until age 80
|
E.
|
it rises
rapidly from young adulthood until the age of 40-50, then stays constant
until age 80
|
F.
|
it rises
rapidly from puberty until the menopause, then stays constant until age 80
|
G.
|
it rises
rapidly from young adulthood until the menopause, then stays constant until
age 80
|
H.
|
none of the
above
|
Scenario 15.
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA1.
She attends the
gynaecology clinic requesting information about the benefits of prophylactic salpingo-oophorectomy.
What are the disadvantages of BSO?
Scenario 16
A woman of 30
has two sisters who developed breast cancer before the age of 40. They and she
have been proved to be carriers of BRCA1.
She attends the
gynaecology clinic requesting information about the benefits of prophylactic salpingo-oophorectomy. What alternatives should be discussed?
Scenario 17
A woman of 25
years is a known carrier of BRCA1. She has no family history of breast cancer.
She has a friend who is similar in age and has similar risk factors for breast
cancer, including being a BRCA1 carrier, apart from having two 1st.
degree relatives with breast cancer. Which, if any of the following statements
is true in relation to the risk of breast cancer for the friend compared with
the woman?
A.
|
her risk is
the same
|
B.
|
her risk is 2
x that of the woman
|
C.
|
her risk is 5x
that of the woman
|
D.
|
her risk is ½
of that of the woman
|
E.
|
none of the above
|
Scenario 18
A woman of 25
years is a known carrier of BRCA2. She has no family history of breast cancer.
She has a friend who is similar in age and has similar risk factors for breast
cancer, including being a BRCA2 carrier, apart from having two 1st.
degree relatives with breast cancer. Which, if any of the following statements
is true in relation to the risk of breast cancer for the friend compared with
the woman?
A.
|
her risk is
the same
|
B.
|
her risk is 2
x that of the woman
|
C.
|
her risk is 5x
that of the woman
|
D.
|
her risk is ½
of that of the woman
|
E.
|
none of the above
|
44. EMQ. Staging of
cervical cancer.
Option list.
1.
Micro-invasive cervical cancer.
2.
Stage Ia1
3.
Stage Ia2
4.
Stage Ia3
5.
Stage Ib1
6.
Stage Ib2
7.
Stage Ib3
8.
Stage IIa
9.
Stage IIb
10.
Stage IIc
11.
Stage IIIa
12.
Stage IIIb
13.
Stage IIIc
14.
Stage IVa
15.
Stage IVb
16.
Stage IVc
17.
Stage Va
18.
Stage Vb
19.
Stage Vc
20.
None of the above.
Scenario 1.
A woman of 25 has a cone biopsy. The histology report shows
squamous cell carcinoma penetrating to a depth of 2 mm and 6 mm in width. The
resection margins are tumour-free. There is no evidence of spread outside the
uterus. She is nulliparous and wishes to retain her fertility.
Scenario 2.
A woman of 25
has a cone biopsy. The histology report shows squamous cell carcinoma
penetrating to a depth of 5 mm and 6 mm in width. The resection margins are
tumour-free. There is no evidence of spread outside the uterus. She is
nulliparous and wishes to retain her fertility.
Scenario 3.
A woman of 25 has a cone biopsy. The histology report shows
squamous cell carcinoma penetrating to a depth of 5 mm and 6 mm in width. The
resection margins are not tumour-free. There is no evidence of spread outside
the uterus. She is nulliparous and wishes to retain her fertility.
Scenario 4.
A woman of 25 has a cone biopsy. The histology report shows
squamous cell carcinoma penetrating to a depth of 6 mm and 3 cm in width. The
resection margins are tumour-free. There is no evidence of extension outside
the uterus. She is nulliparous and wishes to retain her fertility.
Scenario 5.
A woman of 25 has a cone biopsy. The histology report shows
squamous cell carcinoma penetrating to a depth of 6 mm and 5 cm in width. The
resection margins are tumour-free. She is nulliparous and wishes to retain her
fertility.
Scenario 6.
A woman of 38 has a cone biopsy. The histology report shows
squamous cell carcinoma penetrating to a depth of 4 mm and 6mm in width. The
resection margins are tumour-free. An MR scan shows involvement of the
lymphatic nodes in the left of the pelvis.
Scenario 7.
A woman of 45 has carcinoma of the cervix. It extends into
the parametrium, but not to the pelvic side-wall. It involves the upper 1/3 of
the vagina. There is MR evidence of para-aortic node involvement.
Scenario 8.
A woman of 55 has carcinoma of the cervix. It extends to
the pelvic side-wall. It involves the upper 1/3 of the vagina. She has a
secondary on the end of her nose.
Scenario 9.
A woman of 55 has carcinoma of the cervix. It involves the
bladder mucosa.
Scenario 10.
A woman of 35 has a proven cancer of the cervix with
extension into the right parametrium, but not to the pelvic side-wall. Left
hydroureter and left non-functioning kidney are noted on IVP and there is no other
explanation for the findings. Cystoscopy shows bullous oedema of the bladder
mucosa.
Scenario 11.
A woman of 25 has a cone biopsy. It shows malignant
melanoma. The lesion invades to a depth of 3 mm and is 5 mm in width. The
margins of the biopsy are clear. There is evidence of lymphatic vessel
involvement. There is no evidence of spread outside the uterus.
I GOT CURED FROM HERPES WITHIN 14 DAYS, AFTER USING DR Ojoka HERBAL MEDICINE. am out here to testify about how Dr Ojoka cured my (HERPES SIMPLEX VIRUS) i visited different hospital but they gave me list of drugs which were expensive to treat the virus but to no avail. I was browsing through the Internet searching for remedy on HERPES and i saw comment of people talking about how Dr Ojoka them. when i contacted him he gave me hope and send a Herbal medicine to me which i first thought wont solve anything but later i gave it a try and it seriously worked, my HERPES result came out negative. I am so happy as i am sharing this testimony. My advice to you all who thinks that their is no cure for herpes and also no genuine spell caster that is Not true just contact him and get cured today Dr Ojoka spell shrine can cure all kinds of sickness.Remember delay in treatment leads to death email him (dr.ojokarootandherbal@gmail com}. HE IS ALSO SPECIALIZED IN THE TREATMENT OF VARIOUS AILMENT 1 HIV/AIDS VIRUS 2 CANCER DISEASE 3 TUMOR DISEASE ETC 4 HEPATITIS 5 KIDNEY PROBLEM 6 MASTURBATION 7 WEAK ERECTION EMAIL HIM TODAY whatsapp him +2348144172934 check his blog: https://perfectherbalcure.blogspot.com/ check his blog: https://penisherbalenlarge.blogspot.com/ FB page https://www.facebook.com/Sayo-Herbal-Healer-100145798345000/
ReplyDeleteI GOT CURED FROM HERPES WITHIN 14 DAYS, AFTER USING DR Ojoka HERBAL MEDICINE. am out here to testify about how Dr Ojoka cured my (HERPES SIMPLEX VIRUS) i visited different hospital but they gave me list of drugs which were expensive to treat the virus but to no avail. I was browsing through the Internet searching for remedy on HERPES and i saw comment of people talking about how Dr Ojoka them. when i contacted him he gave me hope and send a Herbal medicine to me which i first thought wont solve anything but later i gave it a try and it seriously worked, my HERPES result came out negative. I am so happy as i am sharing this testimony. My advice to you all who thinks that their is no cure for herpes and also no genuine spell caster that is Not true just contact him and get cured today Dr Ojoka spell shrine can cure all kinds of sickness.Remember delay in treatment leads to death email him (dr.ojokarootandherbal@gmail com}. HE IS ALSO SPECIALIZED IN THE TREATMENT OF VARIOUS AILMENT 1 HIV/AIDS VIRUS 2 CANCER DISEASE 3 TUMOR DISEASE ETC 4 HEPATITIS 5 KIDNEY PROBLEM 6 MASTURBATION 7 WEAK ERECTION EMAIL HIM TODAY whatsapp him +2348144172934 check his blog: https://perfectherbalcure.blogspot.com/ check his blog: https://penisherbalenlarge.blogspot.com/ FB page https://www.facebook.com/Sayo-Herbal-Healer-100145798345000/